Skip to content
HowShorted

Twist Bioscience Corp short interest in 2022

In 2022, Twist Bioscience Corp's disclosed short interest ran from 10.10% of shares outstanding on 14 Jan 2022 to 15.50% on 30 Dec 2022, a change of +5.40 percentage points. The year's high was 15.50% on 30 Dec 2022 and its low 10.02% on 15 Aug 2022, averaging 11.85% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 9.77 days on 14 Apr 2022. Full history: Twist Bioscience Corp.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Twist Bioscience Corp in 2022

2022 in figures

Start of year
10.10% (14 Jan 2022)
End of year
15.50% (30 Dec 2022)
Change
+5.40 pp
High
15.50% (30 Dec 2022)
Low
10.02% (15 Aug 2022)
Average
11.85%
Highest days to cover
9.77 (14 Apr 2022)
SEC filings marked
8

Every report in 2022

Twist Bioscience Corp short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 202210.10%5.86
31 Jan 202211.05%5.16
15 Feb 202210.65%4.21results (8-K), 10-Q filed
28 Feb 202211.70%7.83
15 Mar 202212.08%8.49
31 Mar 202212.60%7.11
14 Apr 202213.23%9.77
29 Apr 202214.36%8.48
13 May 202214.84%5.27results (8-K), 10-Q filed
31 May 202210.98%5.41
15 Jun 202211.13%4.90
30 Jun 202211.34%4.35
15 Jul 202211.84%5.88
29 Jul 202210.78%6.82
15 Aug 202210.02%4.71results (8-K), 10-Q filed
31 Aug 202210.61%7.39
15 Sep 202211.07%7.06
30 Sep 202210.18%6.20
14 Oct 202210.06%5.59
31 Oct 202210.81%7.30
15 Nov 202210.79%3.57
30 Nov 202214.02%4.72results (8-K), 10-K filed
15 Dec 202214.55%8.16
30 Dec 202215.50%7.75

See also: Twist Bioscience Corp's full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.